Tue, Sep 18 2018. 10 17 PM IST
Nestle, Unilever and Coca-Cola are among bidders for GlaxoSmithKline’s Indian Horlicks nutrition business, expected to fetch more than $4 billion
Tue, Sep 18 2018. 10 48 AM IST
Indian companies are queuing up to return capital to shareholders by way of share buybacks. For now, investors aren’t complaining
Fri, Sep 07 2018. 05 16 PM IST
In other news, L&T Technology Services will buy Graphene Semiconductor Services for Rs 93 crore in an all cash deal, and Aurobindo Pharma has agreed to buy the dermatology business and three manufacturing units of Sandoz
Fri, Sep 07 2018. 09 04 AM IST
BSE Sensex closed 147.01 points up at 38,389.82, while the Nifty 50 ended 52.20 points higher at 11,589.10. Here are the highlights from the markets
Thu, Sep 06 2018. 03 19 PM IST
Aurobindo is acquiring the dermatology business which contributes to 30% of the acquired business’s revenues, with the remaining contributed by the oral solids business
Thu, Sep 06 2018. 09 53 AM IST
An initial $900 million cash payment to the Basel-based Novartis could be followed by $100 million in performance-based payments
Thu, Sep 06 2018. 08 55 AM IST
BSE Sensex closed 224.50 points up at 38,242.81, while the Nifty 50 ends 59.95 points higher at 11,536.90. Here are the highlights from the markets
Fri, Aug 31 2018. 10 04 PM IST
The health ministry had said in April that oxytocin will not be available at retail private chemist stores and that private pharmaceutical companies will have to stop manufacturing the drug from September
Wed, Aug 22 2018. 11 01 AM IST
The proposed sale of GlaxoSmithKline’s India business has attracted interest from potential bidders including Nestle, PepsiCo and Reckitt Benckiser Group
Wed, Aug 22 2018. 08 51 AM IST
Novartis is supportive of Donald Trump’s continued campaign to lower drug prices, won’t raise prices of its drugs for the remainder of this year, says CEO Vasant Narasimhan in an interview
